Related Experiment Video
Updated: Aug 16, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Pharmacotherapy for Essential Hypertension: A Brief Review
Behnam Heidari1, Eleonora Avenatti1, Khurram Nasir1
1Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist, Houston, Texas, US.
Insights
Hypertension affects 15% globally, with many undertreated. New guidelines offer improved treatment strategies to achieve stricter blood pressure goals, focusing on pharmacotherapy effectiveness and patient management.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertension is a major global health issue, causing significant mortality and disability.
- A large proportion of hypertensive patients worldwide do not receive adequate treatment, failing to reach blood pressure targets.
Purpose of the Study:
- To review current pharmacotherapy for hypertension.
- To address key questions regarding treatment initiation, medication efficacy, and cost-effectiveness.
- To outline strategies for optimizing blood pressure control.
Main Methods:
- Review of existing literature on hypertension pharmacotherapy.
- Analysis of treatment guidelines and medication effectiveness data.
- Discussion of generic versus brand-name antihypertensive drugs.
Main Results:
- New guidelines recommend more intensive treatment strategies for better blood pressure control.
- Evidence supports the efficacy of various antihypertensive medications, including cost-effective generic options.
- Optimal treatment selection and adherence are crucial for achieving blood pressure goals.
Conclusions:
- Effective hypertension management requires a comprehensive approach, including appropriate pharmacotherapy and adherence to new guidelines.
- Addressing undertreatment and optimizing treatment strategies are essential to reduce hypertension-related morbidity and mortality.
Abstract:
Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment. Among those who receive treatment, the majority remain undertreated and do not achieve their blood pressure goals. Therefore, new hypertension guidelines introduce more conscientious treatment strategies to maximize the probability of achieving the new strict blood pressure goals compared with the previous guidelines. Who should receive treatment for hypertension? Which antihypertensive medications have the strongest supporting data? Are generic and more affordable medications as effective as expensive brand medications? What are the different treatment strategies to maximize success in controlling blood pressure? Here, we briefly review pharmacotherapy for hypertension and provide answers to these questions as well as some other common questions regarding treatment of hypertension.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension V: Nursing Management
Hypertension II: Pathophysiology
Antihypertensive Drugs: Action of Diuretics
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

